GO:0070773 protein-N-terminal glutamine amidohydrolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070773 defines the enzymatic deamidation of an N-terminal glutamine residue on a protein, converting it to glutamate and releasing ammonium.
• The reaction is catalyzed by protein N-terminal glutamine amidohydrolase (NtQ-amidase), a component of the N-end rule pathway.
• NtQ-amidase activity is essential for generating N-terminal glutamate, which can be further arginylated to create a destabilizing N-degron.
• The human enzyme is a monomeric protein with a conserved catalytic triad and a deep substrate-binding pocket.
• NtQ-amidase has been applied in enzymatic synthesis of dipeptides containing acidic amino acids at the N-terminus.
• Dysregulation of N-end rule components, including NtQ-amidase, is linked to cancer, neurodegeneration, and metabolic disorders.
Description
Protein N-terminal glutamine amidohydrolase activity (GO:0070773) is a molecular function that catalyzes the deamidation of an N-terminal glutamine residue on a protein, yielding an N-terminal glutamate and ammonium. This reaction is a critical initial step in the N-end rule pathway, a conserved proteolytic system that relates the half-life of a protein to the identity of its N-terminal residue. The enzyme responsible, protein N-terminal glutamine amidohydrolase (NtQ-amidase), is also known as NtQ-amidase and is encoded by the gene NTAQ1 in humans. Because N-terminal glutamine is a common feature of many nascent proteins, the activity of NtQ-amidase directly influences protein stability and turnover. Researchers study this enzyme to understand how cells regulate protein degradation, respond to stress, and maintain proteostasis. Moreover, the enzyme has biotechnological potential, as it has been used in the enzymatic synthesis of dipeptides containing acidic amino acids specifically at the N-terminus. Thus, GO:0070773 represents a key enzymatic activity at the interface of protein quality control and applied biocatalysis.
protein-N-terminal glutamine amidohydrolase activity At A Glance
| GO ID | GO:0070773 |
|---|---|
| GO term | protein-N-terminal glutamine amidohydrolase activity |
| Ontology | molecular_function |
| Synonym | NtQ-amidase activity |
| Definition | Catalysis of the reaction: N-terminal L-glutaminyl-[protein] + H2O = N-terminal L-glutamyl-[protein] + NH4+. This reaction is the deamidation of an N-terminal glutamine residue of a protein. |
| Major function | Deamidation of N-terminal glutamine to glutamate, a step in the N-end rule pathway |
| EC number | Not assigned in QuickGO |
| Reaction direction | Irreversible hydrolysis |
| Substrate | Protein with N-terminal L-glutamine |
| Product | Protein with N-terminal L-glutamate and ammonium |
What Is GO:0070773?
In my own words, GO:0070773 describes the catalytic activity of an enzyme that removes an ammonia molecule from an N-terminal glutamine residue of a protein, converting it to an N-terminal glutamate. The reaction consumes water and releases ammonium. This deamidation modifies the protein's N-terminus, which can alter its stability, localization, or interactions. The activity is synonymous with NtQ-amidase activity and is part of the N-end rule pathway.
Why Is protein-N-terminal glutamine amidohydrolase activity Important in Cell Biology?
GO:0070773 is important because it initiates a cascade that determines protein fate. By converting N-terminal glutamine to glutamate, it creates a substrate for further modification by arginyl-tRNA transferase, which adds an arginine residue and generates a primary destabilizing N-degron. This process is central to the N-end rule pathway, which controls the half-life of many regulatory proteins, including those involved in apoptosis, DNA repair, and stress responses. Consequently, the activity of NtQ-amidase influences diverse cellular processes such as cell cycle progression, signal transduction, and immune response. In biotechnology, the enzyme's ability to specifically deamidate N-terminal glutamine has been harnessed for the synthesis of dipeptides with acidic N-termini, demonstrating its practical utility. Therefore, understanding GO:0070773 provides insights into both fundamental cell biology and potential therapeutic and industrial applications.
• Controls protein half-life by generating N-terminal glutamate, a prerequisite for arginylation and N-end rule degradation.
• Regulates the stability of proteins with N-terminal glutamine, which are common in nascent polypeptides.
• Plays a role in the cellular response to stress and hypoxia through the N-end rule pathway.
• Influences apoptosis and cell cycle progression by targeting key regulatory proteins for degradation.
• Is implicated in cancer biology, as altered N-end rule activity can affect tumor suppressor and oncoprotein stability.
• Contributes to neurodegeneration when N-end rule components are dysregulated.
• Has been used in industrial biocatalysis for the synthesis of dipeptides containing acidic amino acids.
• Represents a potential drug target for modulating protein degradation pathways.
• Serves as a model system for studying enzyme mechanism and substrate specificity.
• Provides a tool for protein engineering and synthetic biology.
What Happens During protein-N-terminal glutamine amidohydrolase activity?
Substrate recognition and binding
In simple terms: The enzyme grabs a protein that has a glutamine at its very beginning.
The enzyme specifically recognizes proteins with an N-terminal glutamine residue. Structural studies of human NtQ-amidase reveal a deep substrate-binding pocket that accommodates the N-terminal glutamine, while excluding other amino acids. The enzyme forms a monomer and uses a conserved catalytic triad to position the substrate for hydrolysis.
Catalytic deamidation
In simple terms: The enzyme cuts off an ammonia group from the glutamine, turning it into glutamate.
Once bound, the enzyme catalyzes the hydrolysis of the side-chain amide of glutamine, releasing ammonium and leaving glutamate at the N-terminus. This reaction is irreversible and requires water. The catalytic mechanism involves a nucleophilic attack on the amide carbon, facilitated by the catalytic triad.
Product release and downstream processing
In simple terms: The modified protein is released and can now be tagged for destruction.
After deamidation, the N-terminal glutamate can be recognized by arginyl-tRNA transferase, which adds an arginine residue. This arginylation creates a destabilizing N-degron, leading to ubiquitination and proteasomal degradation. Thus, the activity of NtQ-amidase is a gateway to the N-end rule pathway.
Role in the N-end rule pathway
In simple terms: This enzyme is the first step in a system that decides which proteins get destroyed.
The N-end rule pathway is a conserved proteolytic system that targets proteins based on their N-terminal residues. NtQ-amidase acts as an initial component by converting N-terminal glutamine to glutamate, which is then arginylated. This two-step process is essential for the degradation of many proteins with N-terminal glutamine, including those involved in apoptosis and stress responses.
Key Genes Involved in GO:0070773 protein-N-terminal glutamine amidohydrolase activity
The following genes and proteins are directly or indirectly associated with protein-N-terminal glutamine amidohydrolase activity and the N-end rule pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NTAQ1 | Encodes protein N-terminal glutamine amidohydrolase (NtQ-amidase) | Core enzyme for GO:0070773; structural and mechanistic studies |
| ATE1 | Arginyl-tRNA transferase that adds arginine to N-terminal glutamate | Downstream of NtQ-amidase in the N-end rule pathway |
| UBR1 | E3 ubiquitin ligase that recognizes N-degrons | Mediates degradation of proteins after NtQ-amidase action |
| UBR2 | E3 ubiquitin ligase involved in N-end rule | Alternative recognition component |
| UBR4 | E3 ubiquitin ligase | Potential downstream effector |
| UBR5 | E3 ubiquitin ligase | Implicated in stress responses |
| NTAQ1 | Also known as NtQ-amidase | Biocatalytic applications |
| RARS | Arginyl-tRNA synthetase | Provides arginyl-tRNA for arginylation |
| NTAQ1 | Human enzyme | Drug target potential |
| NTAQ1 | Monomeric structure | Model for enzyme design |
| NTAQ1 | Catalytic triad | Mechanistic studies |
| NTAQ1 | Substrate specificity | Protein engineering |
| NTAQ1 | N-terminal glutamine deamidation | Biotechnology |
| NTAQ1 | N-end rule pathway | Cancer research |
| NTAQ1 | N-end rule pathway | Neurodegeneration |
| NTAQ1 | N-end rule pathway | Metabolic disorders |
| NTAQ1 | N-end rule pathway | Immunity |
| NTAQ1 | N-end rule pathway | Cell cycle |
How Is protein-N-terminal glutamine amidohydrolase activity Regulated?
The activity of protein-N-terminal glutamine amidohydrolase is regulated at multiple levels. Transcription of NTAQ1 can be induced by stress conditions, and the enzyme's activity may be modulated by post-translational modifications. However, specific regulatory mechanisms are not fully defined in the provided literature. The N-end rule pathway itself is regulated by the availability of arginyl-tRNA and the activity of E3 ligases.
protein-N-terminal glutamine amidohydrolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NTAQ1 | Cancer | Knockout in cancer cell lines (e.g., HeLa) followed by proliferation assays |
| NTAQ1 | Neurodegeneration | Neuronal cell lines with overexpression or knockdown |
| NTAQ1 | Metabolic disorders | Liver-specific knockout mice |
| ATE1 | Cancer | Knockout in tumor models |
| UBR1 | Neurodegeneration | Patient-derived iPSCs |
Cancer
Dysregulation of the N-end rule pathway, including NtQ-amidase, has been implicated in cancer. Altered degradation of proteins with N-terminal glutamine can affect the stability of oncoproteins and tumor suppressors, contributing to tumorigenesis.
Neurodegeneration
Impaired N-end rule activity is associated with neurodegenerative diseases. Accumulation of undegraded proteins due to defective NtQ-amidase function may contribute to neuronal toxicity.
Metabolic disorders
The N-end rule pathway regulates metabolic enzymes, and its dysfunction may lead to metabolic imbalances. NtQ-amidase activity could influence the stability of key metabolic regulators.
From protein-N-terminal glutamine amidohydrolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NTAQ1 knockout affect protein stability? | CRISPR knockout in HEK293T cells |
| What is the catalytic mechanism? | Point mutations in catalytic triad residues |
| How does NtQ-amidase interact with substrates? | Knock-in of tagged NTAQ1 |
| Can NtQ-amidase be used for dipeptide synthesis? | Overexpression in E. coli |
| What is the role of NtQ-amidase in cancer? | Xenograft models with NTAQ1 knockout |
| Does NtQ-amidase regulate specific proteins? | Proteomics after knockout |
How to Study the protein-N-terminal glutamine amidohydrolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Three-dimensional structure | Mechanistic studies |
| Enzymatic assay | Deamidation activity | Kinetic analysis |
| Mass spectrometry | Protein N-terminal modifications | Target identification |
| CRISPR knockout | Gene function | Loss-of-function studies |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Ribo-seq | Translation efficiency | Global protein synthesis |
| Immunoprecipitation | Protein interactions | Complex identification |
Structural biology
X-ray crystallography and cryo-EM can determine the structure of NtQ-amidase alone and in complex with substrate analogs, revealing the catalytic mechanism and substrate specificity.
Enzymatic assays
In vitro assays using synthetic peptides with N-terminal glutamine can measure deamidation activity by detecting ammonium release or glutamate formation.
Proteomics
Mass spectrometry-based proteomics can identify proteins with altered N-terminal residues upon NtQ-amidase knockout or overexpression, uncovering downstream targets.
CRISPR screening
Genome-wide CRISPR screens can identify genes that modulate NtQ-amidase activity or compensate for its loss, revealing pathway interactions.
How CRISPR Can Be Used to Study GO:0070773 protein-N-terminal glutamine amidohydrolase activity
Knockout
CRISPR knockout of NTAQ1 can abolish NtQ-amidase activity, leading to accumulation of proteins with N-terminal glutamine. This model is useful for studying the enzyme's role in protein degradation and cell physiology.
Point Mutation
Introducing point mutations in the catalytic triad of NTAQ1 (e.g., substituting active-site residues) can dissect the enzymatic mechanism and separate catalytic activity from potential scaffolding functions.
Knock-in
Knock-in of a tagged version of NTAQ1 (e.g., FLAG or GFP) allows for localization, interaction, and affinity purification studies under endogenous regulation.
Overexpression
Overexpression of NTAQ1 in cell lines or E. coli can produce large amounts of enzyme for biochemical and structural studies, as well as for biotechnological applications such as dipeptide synthesis.
How EDITGENE Supports protein-N-terminal glutamine amidohydrolase activity Research
Researchers studying protein-N-terminal glutamine amidohydrolase activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for protein-N-terminal glutamine amidohydrolase activity research.
Frequently Asked Questions About protein-N-terminal glutamine amidohydrolase activity
What is protein-N-terminal glutamine amidohydrolase activity?
It is the enzymatic activity that removes an ammonia group from an N-terminal glutamine residue of a protein, converting it to glutamate. This activity is classified as GO:0070773.
What genes are involved in protein-N-terminal glutamine amidohydrolase activity?
The primary gene is NTAQ1, which encodes the enzyme NtQ-amidase. Other genes in the N-end rule pathway include ATE1 and UBR1.
What is the function of NtQ-amidase?
NtQ-amidase catalyzes the deamidation of N-terminal glutamine, an initial step in the N-end rule pathway that leads to protein degradation.
How is protein-N-terminal glutamine amidohydrolase activity regulated?
Regulation occurs at transcriptional and post-translational levels, and through the availability of downstream components like arginyl-tRNA.
What diseases are associated with protein-N-terminal glutamine amidohydrolase activity?
Dysregulation has been linked to cancer, neurodegeneration, and metabolic disorders.
What methods are used to study protein-N-terminal glutamine amidohydrolase activity?
Common methods include X-ray crystallography, enzymatic assays, mass spectrometry, and CRISPR knockout models.
Can protein-N-terminal glutamine amidohydrolase be used in biotechnology?
Yes, it has been applied in the enzymatic synthesis of dipeptides containing acidic amino acids at the N-terminus.
What is the N-end rule pathway?
It is a cellular system that targets proteins for degradation based on their N-terminal amino acid, and NtQ-amidase is an initial component.
What is the structure of human NtQ-amidase?
The human enzyme is a monomer with a conserved catalytic triad and a deep substrate-binding pocket, as revealed by crystal structure.
How can CRISPR be used to study NtQ-amidase?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to investigate the enzyme's function and interactions.
Conclusion
Protein-N-terminal glutamine amidohydrolase activity (GO:0070773) is a fundamental enzymatic function that bridges protein modification and degradation. By deamidating N-terminal glutamine, NtQ-amidase sets the stage for the N-end rule pathway, influencing protein stability and diverse cellular processes. Its roles in cancer, neurodegeneration, and metabolism make it a compelling target for further research. Additionally, its biotechnological potential in dipeptide synthesis highlights its versatility. Continued investigation using advanced CRISPR models and structural techniques will deepen our understanding of this important activity.
References
- 1. Park MS et al.. 2014. Crystal structure of human protein N-terminal glutamine amidohydrolase, an initial component of the N-end rule pathway.. PLoS One 9(10):e111142 PMID: 25356641
- 2. Arai T et al.. 2013. Application of protein N-terminal amidase in enzymatic synthesis of dipeptides containing acidic amino acids specifically at the N-terminus.. J Biosci Bioeng 115(4):382-7 PMID: 23218487
